Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Newsletter Update
Diagnostics
Liquid Biopsy | October Round-Up 2026
Liquid Biopsy continued to progress in October, featuring new regulatory milestones, MRD and screening launches, ESMO study results, and notable diagnostics deal activity.
November 17, 2026

Newsletter Update
Diagnostics
Liquid Biopsy | October Round-Up 2026
Liquid Biopsy continued to progress in October, featuring new regulatory milestones, MRD and screening launches, ESMO study results, and notable diagnostics deal activity.
November 17, 2026
Liquid Biopsy
.png)
Newsletter Update
Diagnostics
AI Newsletter | October 2026 Round-Up
Read about the latest updates in the AI space in October 2026.
November 12, 2026
.png)
Newsletter Update
Diagnostics
AI Newsletter | October 2026 Round-Up
Read about the latest updates in the AI space in October 2026.
November 12, 2026
AI / Machine Learning

In The Press
Diagnostics
Management Consulted - Healthcare Consulting in 2027: Two Partners on Trends, Risks, and Myths
Ben van der Schaaf of Arthur D. Little and Stephane Budel of DeciBio sat down with moderator Ish Mawla to talk about why specialist firms beat much larger ones, where AI is overhyped, what private equity now asks for, and what their firms look for in new hires.
November 11, 2026

In The Press
Diagnostics
Management Consulted - Healthcare Consulting in 2027: Two Partners on Trends, Risks, and Myths
Ben van der Schaaf of Arthur D. Little and Stephane Budel of DeciBio sat down with moderator Ish Mawla to talk about why specialist firms beat much larger ones, where AI is overhyped, what private equity now asks for, and what their firms look for in new hires.
November 11, 2026
NGS
Clinical Diagnostics

DeciBio News
Diagnostics
DeciBio Launches Market Intelligence Portal With DeciChat, an AI Assistant Powered by DeciBio’s Proprietary Precision Medicine Research
DeciChat synthesizes thousands of data points across primary data sources to deliver deep insights into precision medicine markets instantly.
November 6, 2026

DeciBio News
Diagnostics
DeciBio Launches Market Intelligence Portal With DeciChat, an AI Assistant Powered by DeciBio’s Proprietary Precision Medicine Research
DeciChat synthesizes thousands of data points across primary data sources to deliver deep insights into precision medicine markets instantly.
November 6, 2026
DeciBio News
AI / Machine Learning
Diagnostics Market
DeciBio Data Insights
DxBooks Data Insights

Newsletter Update
Investors
Healthcare Investment | October Roundup 2026
October 2026 was defined by mega-licensing agreements, strategic acquisitions, and continued momentum in the biotech IPO market, with three major partnerships collectively exceeding $30 billion in potential value.
November 5, 2026

Newsletter Update
Investors
Healthcare Investment | October Roundup 2026
October 2026 was defined by mega-licensing agreements, strategic acquisitions, and continued momentum in the biotech IPO market, with three major partnerships collectively exceeding $30 billion in potential value.
November 5, 2026
Precision Medicine
DeciBio Ventures
Private Equity
.png)
Newsletter Update
Pharma
Next-Generation Therapeutics | October Round-Up 2026
Read about the latest updates in the Next-Generation Therapeutics space in the month of October.
November 4, 2026
.png)
Newsletter Update
Pharma
Next-Generation Therapeutics | October Round-Up 2026
Read about the latest updates in the Next-Generation Therapeutics space in the month of October.
November 4, 2026
Next-Generation Therapeutics
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved




